02-05-2025
Biotech Stock Ends Week On High Note Following Bullish Coverage Initiation
A New Jersey-based biotech found success to finish out the week after it was announced that TD Cowen initiated coverage on the company with a buy rating and a price target of $12. Seeing that this micro cap closed yesterday at just $2.71, it's now wonder traders rushed in.
So far this session, the buying pressure was enough to get shares of Grace Therapeutics Inc. (Nasdaq:GRCE) up to $2.8604/share (+5.55%) at the early session high. This move is a strong continuation of the success this stock has had so far this month.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
View more of this article on
About Media, Inc.:
Founded in 1999, is one of North America's leading platforms for micro-cap insights.
Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders.
is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.
Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today.
Contact:
Media, Inc.
